Zwart-van Rijkom JE - Search Results

1

Thirty years of hemophilia treatment in the Netherlands, 1972-2001.

Plug I, van der Bom JG, Peters M, Mauser-Bunschoten EP, de Goede-Bolder A, Heijnen L, Smit C, Zwart-van Rijkom JE, Willemse J, Rosendaal FR. Plug I, et al. Blood. 2004 Dec 1;104(12):3494-500. doi: 10.1182/blood-2004-05-2008. Epub 2004 Aug 12. Blood. 2004. PMID: 15308570 Free article.

2

The uptake of recombinant Factor VIII in the Netherlands.

Zwart-van Rijkom JE, Plug I, Rosendaal FR, Leufkens HG, Broekmans AW; Study Group Haemophilia in The Netherlands. Zwart-van Rijkom JE, et al. Br J Haematol. 2002 Nov;119(2):332-41. doi: 10.1046/j.1365-2141.2002.03903.x. Br J Haematol. 2002. PMID: 12406065 Free article.

3

Analysis of potential drug-drug interactions in medical intensive care unit patients.

Uijtendaal EV, van Harssel LL, Hugenholtz GW, Kuck EM, Zwart-van Rijkom JE, Cremer OL, Egberts TC. Uijtendaal EV, et al. Among authors: zwart van rijkom je. Pharmacotherapy. 2014 Mar;34(3):213-9. doi: 10.1002/phar.1395. Epub 2014 Jan 4. Pharmacotherapy. 2014. PMID: 24390929

4

From HMG through purified urinary FSH preparations to recombinant FSH: a substitution study.

Zwart-van Rijkom JE, Broekmans FJ, Leufkens HG. Zwart-van Rijkom JE, et al. Hum Reprod. 2002 Apr;17(4):857-65. doi: 10.1093/humrep/17.4.857. Hum Reprod. 2002. PMID: 11925373 Review.

5

Variability in abciximab (ReoPro) prescribing: evidence based or budget driven?

Zwart-van Rijkom JE, Leufkens HG, Simoons ML, Broekmans AW. Zwart-van Rijkom JE, et al. Pharmacoepidemiol Drug Saf. 2002 Mar;11(2):135-41. doi: 10.1002/pds.689. Pharmacoepidemiol Drug Saf. 2002. PMID: 11998538

6

Differences in attitudes, knowledge and use of economic evaluations in decision-making in The Netherlands. The Dutch results from the EUROMET Project.

Zwart-van Rijkom JE, Leufkens HG, Busschbach JJ, Broekmans AW, Rutten FF. Zwart-van Rijkom JE, et al. Pharmacoeconomics. 2000 Aug;18(2):149-60. doi: 10.2165/00019053-200018020-00005. Pharmacoeconomics. 2000. PMID: 11067649

7

Diffusion of new medicines into hospital practice.

Zwart-van Rijkom JE, Breekveldt-Postma NS, Leufkens HG, Egberts AC. Zwart-van Rijkom JE, et al. Eur J Clin Pharmacol. 2003 Sep;59(5-6):495-6. doi: 10.1007/s00228-003-0642-y. Epub 2003 Aug 9. Eur J Clin Pharmacol. 2003. PMID: 12910330 No abstract available.

8

Costs and effects of combining stenting and abciximab (ReoPro) in daily practice.

Zwart-van Rijkom JE, Klungel OH, Leufkens HG, Broekmans AW, Schrijver-van Velthoven S, Umans VA. Zwart-van Rijkom JE, et al. Int J Cardiol. 2001 Feb;77(2-3):299-303. doi: 10.1016/s0167-5273(00)00453-8. Int J Cardiol. 2001. PMID: 11182196

9

[Rising costs of drugs in hospitals in the period 1996-2000 and over the next few years].

Breekveldt-Postma NS, Zwart-van Rijkom JE, Egberts AC, Leufkens HG, Herings RM. Breekveldt-Postma NS, et al. Ned Tijdschr Geneeskd. 2002 Dec 28;146(52):2547-51. Ned Tijdschr Geneeskd. 2002. PMID: 12532669 Dutch.

10

Frequency and nature of drug-drug interactions in a Dutch university hospital.

Zwart-van Rijkom JE, Uijtendaal EV, ten Berg MJ, van Solinge WW, Egberts AC. Zwart-van Rijkom JE, et al. Br J Clin Pharmacol. 2009 Aug;68(2):187-93. doi: 10.1111/j.1365-2125.2009.03443.x. Br J Clin Pharmacol. 2009. PMID: 19694737 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

22 results

Search Page